GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » 3-Year Dividend Growth Rate

Taisho Pharmaceutical Holdings Co (TSE:4581) 3-Year Dividend Growth Rate : -3.10% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co 3-Year Dividend Growth Rate?

Taisho Pharmaceutical Holdings Co's Dividends per Share for the three months ended in Dec. 2023 was 円0.00.

The historical rank and industry rank for Taisho Pharmaceutical Holdings Co's 3-Year Dividend Growth Rate or its related term are showing as below:

TSE:4581' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -5.9   Med: 0.05   Max: 33.9
Current: -3.1

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Taisho Pharmaceutical Holdings Co was 33.90% per year. The lowest was -5.90% per year. And the median was 0.05% per year.

TSE:4581's 3-Year Dividend Growth Rate is ranked worse than
72.76% of 323 companies
in the Drug Manufacturers industry
Industry Median: 9.1 vs TSE:4581: -3.10

During the past 3 years, the average Dividends Per Share Growth Rate was -3.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -2.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Taisho Pharmaceutical Holdings Co's Dividend Yield % is 1.17%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Taisho Pharmaceutical Holdings Co's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Taisho Pharmaceutical Holdings Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taisho Pharmaceutical Holdings Co's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taisho Pharmaceutical Holdings Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Taisho Pharmaceutical Holdings Co's 3-Year Dividend Growth Rate falls into.



Taisho Pharmaceutical Holdings Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Taisho Pharmaceutical Holdings Co  (TSE:4581) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 36.557
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Taisho Pharmaceutical Holdings Co was 0.74. The lowest was 0.27. And the median was 0.36.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Taisho Pharmaceutical Holdings Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
JPY 9999999.9992023-09-282023-09-302023-12-04Cash Dividendsemi-annuallyJPY:JPY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Taisho Pharmaceutical Holdings Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=9999999.999/231891891891.89
=0.00 %

Current Share Price is 円231891891891.89.
Taisho Pharmaceutical Holdings Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is 円9999999.999.

During the past 13 years, the highest Dividend Yield of Taisho Pharmaceutical Holdings Co was 2.13%. The lowest was 0.79%. And the median was 1.45%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taisho Pharmaceutical Holdings Co 3-Year Dividend Growth Rate Related Terms>


Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines